chalcone has been researched along with Cardiomegaly in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jing, Y; Liu, S; Ni, B; Zhou, D | 1 |
| Mei, X; Wang, J; Zhang, Q; Zhang, X | 1 |
2 other study(ies) available for chalcone and Cardiomegaly
| Article | Year |
|---|---|
Hydroxysafflor yellow A protects against angiotensin II‑induced hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Chalcone; Disease Models, Animal; Heme Oxygenase-1; Male; Myocardial Infarction; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Protective Agents; Quinones; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Hydroxysafflor yellow A attenuates left ventricular remodeling after pressure overload-induced cardiac hypertrophy in rats.
Topics: Animals; Apoptosis; Captopril; Cardiomegaly; Carthamus tinctorius; Chalcone; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Hypertension; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medicine, Chinese Traditional; Myocytes, Cardiac; Quinones; Rats; Rats, Wistar; Ventricular Remodeling | 2014 |